Management of sporadic and familial hemiplegic migraine

References

• Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia24(Suppl. 1), 1–160 (2004).
   Web of Science ®Google Scholar
• Russell MB, Iversen HK, Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia14(2), 107–117 (1994).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB. A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain125(6), 1379–1391 (2002).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Østergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology60(4), 595–601 (2003).
   PubMed Web of Science ®Google Scholar
• Ducros A, Denier C, Joutel A et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N. Engl. J. Med.345(1), 17–24 (2001).
   PubMed Web of Science ®Google Scholar
• Swoboda KJ, Kanavakis E, Xaidara A et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann. Neurol.55(6), 884–887 (2004).
   PubMed Web of Science ®Google Scholar
• Kaunisto MA, Harno H, Vanmolkot KR et al. A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2. Neurogenetics5(2), 141–146 (2004).
   PubMed Web of Science ®Google Scholar
• Castro MJ, Stam AH, Lemos C et al. Recurrent ATP1A2 mutations in Portuguese families with familial hemiplegic migraine. J. Hum. Genet.52(12), 990–998 (2007).
   PubMed Web of Science ®Google Scholar
• Vanmolkot KR, Stam AH, Raman A et al. First case of compound heterozygosity in Na,K-ATPase gene ATP1A2 in familial hemiplegic migraine. Eur. J. Hum. Genet.15(8), 884–888 (2007).
   PubMed Web of Science ®Google Scholar
• de Vries B, Freilinger T, Vanmolkot KR et al. Systematic analysis of three FHM genes in 39 sporadic patients with hemiplegic migraine. Neurology69(23), 2170–2176 (2007).
   PubMed Web of Science ®Google Scholar
• Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell87(3), 543–552 (1996).
   PubMed Web of Science ®Google Scholar
• De Fusco M, Marconi R, Silvestri L et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet.33(2), 192–196 (2003).
   PubMed Web of Science ®Google Scholar
• Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet366(9483), 371–377 (2005).
   PubMed Web of Science ®Google Scholar
• Zhuchenko O, Bailey J, Bonnen P et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the a 1A-voltage-dependent calcium channel. Nat. Genet.15(1), 62–69 (1997).
   PubMed Web of Science ®Google Scholar
• Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. de novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet.68(6), 1327–1332 (2001).
   PubMed Web of Science ®Google Scholar
• Escayg A, MacDonald BT, Meisler MH et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat. Genet.24(4), 343–345 (2000).
   PubMed Web of Science ®Google Scholar
• Riant F, De Fusco M, Aridon P et al. ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum. Mutat.26(3), 281 (2005).
   PubMedGoogle Scholar
• Vanmolkot KR, Babini E, de Vries B et al. The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Hum. Mutat.28(5), 522 (2007).
   PubMedGoogle Scholar
• Thomsen LL, Kirchmann M, Bjornsson A et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine. Brain130(Pt 2), 346–356 (2007).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Østergaard E, Bjornsson A et al. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia28(9), 914–921 (2008).
   PubMed Web of Science ®Google Scholar
• Leão AAP. Spreading depression of activity in the cerebral cortex. J. Neurophysiol.7, 359–390 (1944).
   Google Scholar
• Leão AAP. Further observations on the spreading depression of activity in the cerebral cortex. J. Neurophysiol.10, 409–414 (1944).
   Google Scholar
• Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann. Neurol.9(4) 344–352 (1981).
   PubMed Web of Science ®Google Scholar
• Lauritzen M, Skyhøj Olsen T, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann. Neurol.13(6), 633–641 (1983).
   PubMed Web of Science ®Google Scholar
• Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain107(Pt 2), 447–461 (1984).
   PubMed Web of Science ®Google Scholar
• Olesen J, Friberg L, Olsen TS et al. Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann. Neurol.28(6), 791–798 (1990).
   PubMed Web of Science ®Google Scholar
• Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA98(8), 4687–4692 (2001).
   PubMed Web of Science ®Google Scholar
• Cutrer FM, Sorensen AG, Weisskoff RM et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann. Neurol.43(1), 25–31 (1998).
   PubMed Web of Science ®Google Scholar
• Olesen J, Tfelt-Hansen P, Henriksen L, Larsen B. The common migraine attack may not be initiated by cerebral ischaemia. Lancet2(8244), 438–440 (1981).
   PubMed Web of Science ®Google Scholar
• Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache.N. Engl. J. Med.331(25), 1689–1692 (1994).
   PubMed Web of Science ®Google Scholar
• Vanmolkot KR, Stroink H, Koenderink JB et al. Severe episodic neurological deficits and permanent mental retardation in a child with a novel FHM2 ATP1A2 mutation. Ann. Neurol.59(2), 310–314 (2006).
   PubMed Web of Science ®Google Scholar
• Kors EE, Terwindt GM, Vermeulen FL et al. Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann. Neurol.49(6), 753–760 (2001).
   PubMed Web of Science ®Google Scholar
• Kors EE, Haan J, Giffin NJ et al. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch. Neurol.60(5), 684–688 (2003).
   PubMedGoogle Scholar
• Vahedi K, Denier C, Ducros A et al.CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology55(7), 1040–1042 (2000).
   PubMed Web of Science ®Google Scholar
• Beauvais K, Cave-Riant F, De Barace C, Tardieu M, Tournier-Lasserve E, Furby A. New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur. Neurol.52(1), 58–61 (2004).
   PubMed Web of Science ®Google Scholar
• Curtain RP, Smith RL, Ovcaric M, Griffiths LR. Minor head trauma-induced sporadic hemiplegic migraine coma. Pediatr. Neurol.34(4), 329–332 (2006).
   PubMed Web of Science ®Google Scholar
• Jurkat-Rott K, Freilinger T, Dreier JP et al. Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology62(10), 1857–1861 (2004).
   PubMed Web of Science ®Google Scholar
• Deprez L, Weckhuysen S, Peeters K et al. Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia49(3), 500–508 (2008).
   PubMed Web of Science ®Google Scholar
• Mjåset C, Russell MB. Intravenous nimodipine worsening prolonged attack of familial hemiplegic migraine. J. Headache Pain9(6), 381–384 (2008).
   PubMed Web of Science ®Google Scholar
• Fitzsimons RB, Wolfenden WH. Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain108(Pt 3), 555–577 (1985).
   PubMed Web of Science ®Google Scholar
• Holub V, Chrást B, Saxl O. [Fatal outcome of a migraine attack in children]. Kinderaerztl. Prax.33(12), 539–546 (1965).
   PubMedGoogle Scholar
• Neligan P, Harriman DG, Pearce J. Respiratory arrest in familial hemiplegic migraine: a clinical and neuropathological study. Br. Med. J.2(6089), 732–734 (1977).
   PubMedGoogle Scholar
• Castro MJ, Stam AH, Lemos C et al. First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. Cephalalgia29(3), 308–313 (2009).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Olesen J, Russell MB. Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives. Eur. J. Neurol.10(4), 421–427 (2003).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Ostergaard E, Romer SF et al. Sporadic hemiplegic migraine is an aetiologically heterogeneous disorder. Cephalalgia23(9), 921–928 (2003).
   PubMed Web of Science ®Google Scholar
• Russell MB, Rasmussen BK, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine. Int. J. Epidemiol.24(3), 612–618 (1995).
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Østergaard E, Bjornsson A et al. Screen for CACNA1A and ATP1A2 mutations in sporadic hemiplegic migraine patients. Cephalalgia28, 914–921 (2008).
   PubMed Web of Science ®Google Scholar
• Russell MB, Olesen J. Increased familial risk and evidence of genetic factors in migraine. Br. Med. J.311(7004), 541–544 (1995).
   PubMed Web of Science ®Google Scholar
• Tvedskov JF, Iversen HK, Olesen J. A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine. Cephalalgia24(10), 875–882 (2004).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia29(7), 742–750 (2009).
   PubMedGoogle Scholar
• Lauritzen M, Hansen AJ. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression.J. Cereb. Blood Flow Metab.12(2), 223–229 (1992).
   PubMed Web of Science ®Google Scholar
• Kaube H, Herzog J, Käufer T, Dichgans M, Diener HC. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology55(1), 139–141 (2001).
   Web of Science ®Google Scholar
• Bates D, Ashford E, Dawson R et al. Subcutaneous sumatriptan during the migraine aura. Sumatriptan Aura Study Group. Neurology44(9), 1587–1592 (1994).
   PubMed Web of Science ®Google Scholar
• Welch KM, Cao Y, Aurora S et al. MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine. Neurology51(5), 1465–1469 (1998).
   PubMed Web of Science ®Google Scholar
• Bousser MG, Welch KMA. Relation between migraine and stroke. Lancet Neurol.4(9), 533–542 (2005).
   PubMed Web of Science ®Google Scholar
• Artto V, Nissilä M, Wessman M, Palotie A, Färkkilä M, Kallela M. Treatment of hemiplegic migraine with triptans. Eur. J. Neurol.14(9), 1053–1056 (2007).
   PubMed Web of Science ®Google Scholar
• Hsu DA, Stafstrom CE, Rowley HA, Kiff JE, Dulli DA. Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev.30(1), 86–90 (2008).
   PubMed Web of Science ®Google Scholar
• Yu W, Horowitz SH. Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology57(9), 1732–1733 (2001).
   PubMed Web of Science ®Google Scholar
• Vetvik KR, Dahl M, Russell MB. Symptomatic sporadic hemiplegic migraine. Cephalalgia25(11), 1093–1095 (2005).
   PubMed Web of Science ®Google Scholar
• Ho TW, Ferrari MD, Dodick DW et al. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet372(9656), 2115–2123 (2008).
   PubMed Web of Science ®Google Scholar
• Hansen JM, Thomsen LL, Olesen J, Ashina M. Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype. Neurology71(11), 841–847 (2008).
   PubMed Web of Science ®Google Scholar
• Athwal BS, Lennox GG. Acetazolamide responsiveness in familial hemiplegic migraine. Ann. Neurol.40(5), 820–821 (1996).
   PubMedGoogle Scholar
• Battistini S, Stenirri S, Piatti M et al. A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology53(1), 38–43 (1999).
   PubMed Web of Science ®Google Scholar
• Spadaro M, Ursu S, Lehmann-Horn F et al. A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics5(3), 177–185 (2004).
   PubMed Web of Science ®Google Scholar
• Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology55(10), 1588–1589 (2000).
   PubMed Web of Science ®Google Scholar
• Vahedi K, Taupin P, Djomby R et al. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. J. Neurol.249(2), 206–211 (2001).
   Web of Science ®Google Scholar
• Yu W, Horowitz SH. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology60(1), 120–121 (2003).
   PubMed Web of Science ®Google Scholar
• The Headaches. Olesen J, Tfelt-Hansen P, Goadby P, Welch KMA, Ramadan NH (Eds). Lippincott Williams & Wilkins, PA, USA, Chapters 47–60, 433–576 (2006).
   Google Scholar
• Evers S, Afra J, Frese A et al. EFNS guideline on the drug treatment of migraine – report of an EFNS task force. Eur. J. Neurol.13(6), 560–572 (2006).
   PubMed Web of Science ®Google Scholar